Knowledge · Natural substances

Peppermint

Database-based evaluation · 553 studies in our database, 54 of them controlled human trials · As of · How we work

Essential peppermint oil, inhaled or as an enteric-coated capsule, in studies mainly relieved nausea and irritable bowel symptoms.

We evaluated 146 human studies on Peppermint, including 55 randomised controlled trials and 17 meta-analyses or systematic reviews; the controlled studies include 4,562 participants in total. As of 24 October 2026.

This page as PDF · Summary

1. What Is Peppermint? Occurrence, Origin and Forms

Peppermint is a cultivated mint species in the Lamiaceae family. Its leaves and the essential oil obtained from them are used above all. Traditionally it serves as a tea and as an oil, among other things for digestive complaints and for external application.

Peppermint grows in temperate climates and is cultivated worldwide in gardens and in field cultivation. The leaves and the essential oil of the plant are used.

The essential oil is produced by steam distillation of the leaves; for tea the leaves are dried. Studies examine above all tea, essential oil, enteric-coated capsules and leaf extracts.

Forms and Preparations Studied

  • Peppermint tea (infusion of dried leaves)
  • Peppermint essential oil
  • Enteric-coated peppermint oil capsules
  • Peppermint leaf extract
  • Topical preparation (gel or solution)

Not covered on this page:

  • Other mint species such as spearmint (Mentha spicata)
  • Isolated menthol as a single substance
  • Other Lamiaceae such as lemon balm or sage
  • Peppermint flavourings without peppermint constituents

2. What Does Peppermint Do? Results by Area

AreaResult in controlled studiesStrength of evidenceStudiesParticipants
Nauseamixedhigh1 meta-analyses · 14 controlled · 11 other884
Irritable bowel syndromemixedhigh5 meta-analyses · 5 controlled · 32 other783
Cognition and alertnessmostly improvedmoderate0 meta-analyses · 3 controlled · 3 other190
Headache and Migrainemostly no differencelow0 meta-analyses · 2 controlled · 1 other166
Physical performancemostly no differencelow0 meta-analyses · 2 controlled · 1 other21
Functional dyspepsiamostly improvedlow0 meta-analyses · 1 controlled · 9 other60
Respiratory tract and common cold symptomsmostly no differenceunclear0 meta-analyses · 1 controlled · 2 other106
Other investigationsmixedhigh2 meta-analyses · 41 controlled · 36 other2,931

How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.

3. What the Studies Show in Detail

Peppermint and Nausea: Human Studies

After operations, inhaled essential peppermint oil reduced nausea more than the control in several randomized controlled trials, for example after heart, cervical spine and thyroid operations 485773. In breast cancer patients undergoing chemotherapy, ingested peppermint extract drops relieved nausea, vomiting and loss of appetite more than water 44. Nausea and vomiting also occurred less often in randomized controlled trials 374857. The need for anti-nausea medication decreased in randomized controlled trials after cervical spine operations and after knee replacement 4872. A meta-analysis on inhalation of peppermint oil found less postoperative nausea, reduced symptoms in pregnancy-related nausea and a reduction in symptoms in chemotherapy-induced nausea 12. In pregnant women with nausea, inhaled peppermint oil did not relieve symptoms more than placebo 58. After knee replacement, nausea severity remained the same with peppermint scent as with saline solution 72. Peppermint drops taken before a nasal operation lowered the frequency of nausea, but not of vomiting 45. For peppermint tea or enteric-coated capsules, there is no separate controlled test in this area.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Wang et al. 2025meta-analysis · 2,062 participantsPeppermint extract (among 15 plant substances); vs. Standard treatmentNausea: unclear
9 Jin et al. 2026meta-analysis · 336 participantsEssential oil-based interventions, including inhalation aromatherapy and oral peppermint extract; acute phase within 24 h after chemotherapy; vs. control conditionsacute nausea severity: improved (SMD = -0.49, 95% CI -0.76 to -0.22); vomiting frequency: no difference (SMD = -0.25, 95% CI -0.75 to 0.25); vomiting severity/score: improved (SMD = -0.31, 95% CI -0.59 to -0.03)
10 Mascarenhas et al. 2025meta-analysisAromatherapy with essential oils, including peppermint/mint; vs. Conventional treatment, other complementary therapies, or placeboNausea and vomiting: improved (SMD = -0.92; 95 % CI: -1.09, -0.74)
12 Gergő et al. 2025meta-analysisPeppermint oil inhalation; 2 to 96 hours after intervention; vs. ControlNausea 2–6 h after intervention (PONV): improved (MD: -0.60 points, 95% CI: -0.77 to -0.44, p = 0.004); Symptom severity at 48 h (NVP): improved (MD: -0.51, 95% CI: -0.78 to -0.24, p = 0.015); Symptom severity at 96 h (NVP): improved (MD: -0.68, 95% CI: -1.09 to -0.27, p = 0.019)
14 Wang et al. 2024meta-analysisAromatherapy with peppermint oil, ginger essence, lavender; vs. Control/standard careSeverity of postoperative nausea: improved (SMD: -0.93, 95% CI: -1.64 to -0.22; P = 0.010); Vomiting episodes: no difference (SMD: -0.81, 95% CI: -1.98-0.37; P = 0.180)
15 Ahn et al. 2024meta-analysisAromatherapy, including peppermint oil (inhalation, massage); vs. Control groups of included RCTsOverall nausea and vomiting: improved (SMD = -0.81, 95 % CI: -1.11 to -0.52); Nausea: improved (SMD = -0.85, 95 % CI: -1.23 to -0.46); Combined nausea and vomiting: improved (SMD = -1.08, 95 % CI: -1.68 to -0.47)
34 Ahmadi et al. 2020randomised controlled · 120 participantsInhalation of 10% or 30% peppermint essential oil; 0.2 ml of 10% or 30% peppermint oil; Single application, measured after 10 minutes; vs. Distilled water with green food coloringNausea severity (NVAS): unclear (52.3 ± 13.7 auf 40.5 ± 13.5 (p < 0.001)); Nausea severity (NVAS): unclear (60.2 ± 15.0 auf 39.7 ± 12.4 (p < 0.001)); Nausea severity (NVAS): unclear
37 Tang et al. 2026randomised controlled · 106 participantsInhalation with 2% peppermint oil; 2% peppermint oil, inhalation; before induction, preoperatively, immediately after extubation; vs. 2 ml 0.9% sodium chloride inhalationIncidence of PONV within 24 h: improved (52.8% vs. 73.6%; p = 0.043); Incidence of PONV during the first hour: improved (45.3% vs. 73.6%; p = 0.047)

Further studies in this area: 39 41 44 45 48 49 57 58 66 72 73 80 85 87 99 111 132 137

Peppermint and Irritable Bowel Syndrome: Human Studies

In irritable bowel syndrome, peppermint oil, mostly in enteric-coated capsules, improved overall symptoms more than placebo in several meta-analyses 34568. A randomized controlled trial with a peppermint oil released in the small intestine confirmed this for the total symptom score 50. Abdominal pain also improved more than with placebo in several meta-analyses 345. In children with functional abdominal pain, a peppermint oil capsule relieved the duration, frequency and intensity of pain more than placebo 36. This is contrasted by randomized controlled trials: in children with irritable bowel syndrome, peppermint oil was not more effective than placebo 22. In adults, it missed the primary endpoints, but improved abdominal pain, discomfort and severity as secondary endpoints 24. The evidence is strong, but the individual studies are inconsistent; mainly capsules were tested, not tea, and in children the results are contradictory 2236.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
3 Ingrosso et al. 2022meta-analysis · 1,030 participantsPeppermint oil; vs. PlaceboGlobal IBS symptoms (not improving): improved (RR of not improving = 0.65; 95% CI 0.43-0.98); Abdominal pain (not improving): improved (RR of abdominal pain not improving = 0.76; 95% CI 0.62-0.93); Any adverse event (RR of any adverse event = 1.57; 95% CI 1.04-2.37)
4 Alammar et al. 2019meta-analysis · 835 participantsPeppermint oil (PO); vs. PlaceboGlobal symptom improvement: improved (RR 2.39 [95% CI: 1.93, 2.97], p < 0.00001); Abdominal pain: improved (RR 1.78 [95% CI: 1.43, 2.20], p < 0.00001); Adverse effects (RR 1.40 [95% CI: 0.87, 2.26], p = 0.16)
5 Khanna et al. 2014systematic review · 726 participantsEnteric-coated peppermint oil capsules; at least 2 weeks; vs. PlaceboGlobal improvement of IBS symptoms: improved (relative risk 2.23; 95% confidence interval, 1.78-2.81); Improvement in abdominal pain: improved (relative risk 2.14; 95% confidence interval, 1.64-2.79)
6 Huang et al. 2022meta-analysis · 722 participantsPeppermint oil; vs. PlaceboIBS Symptom Severity Scale (IBS-SSS): no difference (MD = 15.35, 95% CI: -25.16-55.86, P = 0.46); IBS quality of life (IBS-QOL): no difference (MD = 0.78, 95% CI: -0.18-1.74, P = 0.11); IBS-Global improvement in symptoms (IBS-GIS): improved (RR = 1.62, 95% CI: 1.20-2.17, P = 0.002)
8 Ford et al. 2008meta-analysis · 392 participantsPeppermint oil; at least one week; vs. PlaceboRelative risk of persistent symptoms: improved (0.43, 0.32 to 0.59)
17 Utz et al. 2024reviewPeppermint oil (essential oil); vs. Guideline recommendations and other phytotherapeuticsGuideline recommendation for pain and flatulence: improved ("strongly recommended")
21 Shen et al. 2009reviewPeppermint oil; vs. other complementary and alternative therapiesIBS symptoms including abdominal pain: improved
22 Vermeijden et al. 2026randomised controlled · 228 participantsPeppermint oil capsules (double-blind) and peppermint sweets (open-label); 182 mg oil or 9.2 mg oil, 2-3 times daily, dose escalation allowed; 8 weeks intervention, 4 weeks follow-up; vs. Placebo (2.0 mg peppermint oil)Treatment success (≥30% pain reduction): no difference (OR, 1.33; 97.5% CI, 0.58-3.09; P = .44); Treatment success (≥30% pain reduction): no difference (OR, 1.05; 97.5% CI, 0.45-2.44; P = .91); Adequate relief of symptoms: no difference (OR, 1.15; 97.5% CI, 0.54-2.47; P = .68)

Further studies in this area: 24 26 36 50 82 88 89 90 106 107 109 110 111 112 113 114 115 117 119 121 122 123 128 129 130 132 133 134 136 138 139 140 141 142

Peppermint, Cognition and Alertness: Human Studies

For cognition and alertness, a randomized controlled trial with peppermint tea shows that cognitive performance in a computer-based test battery improved more in healthy adults than with placebo 64. A systematic review on essential peppermint oil as a scent comes to no clear result 13. The evidence is moderate: there are only a few small controlled studies with different forms (tea, essential oil as a scent); it is open how these act with longer use or in people with cognitive impairment.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
13 Nishi et al. 2025reviewPeppermint (Mentha × piperita L.) essential oil scentCognitive effect of peppermint scent: unclear
40 Mahdavikian et al. 2021randomised controlled · 105 participantsInhalation of 3 drops peppermint essential oil; 3 drops per night; 7 nights; vs. lavender oil and aromatic placeboFatigue (Fatigue Severity Scale): improved (P < 0.001); Fatigue peppermint vs. lavender: no difference
64 Netzler et al. 2025randomised controlled · 25 participantsPeppermint tea, 200 mL; 200 mL tea; short-term (pre-post intervention); vs. Placebo controlCognitive performance (computerized battery): improved
78 Tang et al. 2021controlled · 60 participantsPeppermint odor vs. placebo (air); vs. Peppermint odor vs. placebo; tactile, auditory, combinedAlertness after takeover: improved
100 Lin et al. 2022studyPeppermint essential oil; vs. White, red and blue light stimulationAlpha waves in the prefrontal area: improved; Alpha wave activity in the occipital area: improved
111 Kazemi et al. 2025reviewPeppermint (leaves, essential oil, extracts)Improvement in memory and alertness: improved

Peppermint, Headache and Migraine: Human Studies

The controlled trials in this area concern migraine and chronic headaches in adolescents, not tension-type headache in the narrower sense. In adults with migraine, peppermint oil nasal drops in a randomized controlled trial relieved headaches more than placebo and similarly to lidocaine drops 35. In adolescents with chronic headaches, a foot bath with peppermint oil did not relieve pain more than a foot bath without oil 62. The strength of evidence is low; above all, it is open how peppermint oil acts in tension-type headache.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
20 Lopresti et al. 2020reviewMenthol/peppermint oil as single ingredient; vs. Placebo or other treatmentAcute treatment of migraine: improved (positive, preliminary findings)
35 Rafieian-Kopaei et al. 2019randomised controlled · 120 participantsPeppermint essential oil nasal drops 1.5%; Nasal drops, second dose after 15 min if needed; Follow-up over 2 months; vs. Intranasal lidocaine 4% and placeboHeadache intensity after treatment: improved (P < 0.001); Proportion with considerable response: improved (42.1%); Proportion with decreased headache intensity: improved (40%)
62 Kingsley et al. 2023randomised controlled · 46 participantsFoot bath plus peppermint oil; Brief intervention with baseline, mid- and post-intervention measurements; vs. Foot bath without peppermint oilSubjective pain intensity: no difference

Peppermint and Physical Performance: Human Studies

In recreational runners, essential peppermint oil in water in a randomized controlled trial prolonged running time to exhaustion compared with placebo 67. In healthy participants, however, peak oxygen uptake and endurance time remained unchanged after several days of intake 68. The strength of evidence is low, especially since the groups with 14 and 7 participants were small and the tested form was the essential oil, not tea, extract or enteric-coated capsules. An uncontrolled study with before-and-after comparison reports better endurance time and performance after essential peppermint oil in mineral water, but without a control group it cannot show a causal relationship 93. Whether peppermint oil reliably prolongs endurance must be clarified by larger studies.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
67 Miranda et al. 2023randomised controlled · 14 participantsPeppermint essential oil in water; 0.05 mL oil in 500 mL water, plus 400 mL drink; Run to exhaustion at 70% VO2max; vs. Placebo (water)Time to exhaustion: improved (109.9 ± 6.9 min in PEO and 98.5 ± 6.2 min in PLA (p = 0.009; effect size: 0.826))
68 Shepherd et al. 2017randomised controlled · 7 participantsPeppermint essential oil (PEP); 10 days; vs. Control, randomised crossoverPeak oxygen uptake: no difference (3.54 vs. 3.52 L/min); Time to exhaustion: no difference (583.33 vs. 587.04 s)
93 Meamarbashi et al. 2013study · 12 participantsMineral water with 0.05 ml peppermint essential oil; 0.05 ml peppermint essential oil in 500 ml water daily; 10 days; vs. Before-after comparison without control groupTime to exhaustion: improved (664.5 ± 114.2 vs. 830.2 ± 129.8 s); Work: improved (78.34 ±32.84 vs. 118.7 ± 47.38 KJ); Power: improved (114.3 ± 24.24 vs. 139.4 ± 27.80 KW)

Peppermint and Functional Dyspepsia: Human Studies

For functional dyspepsia, peppermint has so far been tested mainly in fixed mixtures with caraway oil or other medicinal plants, whose effect cannot be attributed to peppermint alone. One randomized controlled trial with essential peppermint oil alone involved ventilated intensive care patients with enteral nutrition and showed a reduced gastric residual volume, not the digestive complaints themselves 56. The effect of peppermint tea and of essential peppermint oil without caraway in functional dyspepsia remains open.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
56 Mohammadzadeh et al. 2022randomised controlled · 60 participantsSupermint Drop (peppermint essential oil) vs. placebo; 20 drops in 40 ml water, three times daily; 4 days; vs. PlaceboGastric residual volume (GRV): improved (1.16 (95% confidence interval: 0.75, 1.57) lower)
82 Storr et al. 2022cross-sectional study · 1,686 participantsPeppermint oil (compared with hyoscine butylbromide and hyoscine butylbromide+paracetamol); vs. HBB and HBB+paracetamolOverall effectiveness for gastrointestinal cramps and pain: no difference
104 Pasta et al. 2026reviewPeppermint-caraway preparationSymptom improvement: improved
109 Moniruzzaman et al. 2025reviewPeppermint oil, ginger, STW-5, ZZKZ, Rikkunshito; vs. Placebo-controlled trialsImprovement of gastrointestinal symptoms: improved
111 Kazemi et al. 2025reviewPeppermint (leaves, essential oil, extracts)Effectiveness in functional dyspepsia: improved
116 Tursi et al. 2025reviewSTW 5-II, fixed combination of six hydroethanolic herbal extracts; vs. Placebo in several controlled studiesEfficacy in functional dyspepsia: improved (more effective than placebo)
122 Scarpellini et al. 2023reviewPeppermint oil; vs. classical pharmacological treatmentsTreatment of functional dyspepsia: improved
124 Yoon et al. 2022reviewPeppermint and caraway (combination); vs. Placebo or other CAMEvidence for efficacy: unclear (limited evidence)

Further studies in this area: 131 132

Peppermint, Respiratory Tract and Common Cold Symptoms: Human Studies

For respiratory tract and cold complaints, the randomized controlled trial with nebulized essential peppermint oil in healthy participants shows no difference in forced vital capacity, peak expiratory flow, and FEV1/FVC ratio compared with eucalyptus oil, rosemary oil, or no treatment 38. A small study without a control group reports improvements in forced vital capacity, peak expiratory flow, and peak inspiratory flow after mineral water with essential peppermint oil, but this design does not allow causal attribution 93.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
38 Köteles et al. 2018randomised controlled · 106 participantsNebulized peppermint essential oil; 15 minutes; vs. Eucalyptus oil, rosemary oil, or no treatmentForced vital capacity: no difference; Peak expiratory flow: no difference; FEV1/FVC ratio: no difference
93 Meamarbashi et al. 2013study · 12 participantsMineral water with 0.05 ml peppermint essential oil; 0.05 ml peppermint essential oil in 500 ml water daily; 10 days; vs. Before-after comparison without control groupForced vital capacity (FVC): improved (4.57 ± 0.90 vs. 4.79 ± 0.84; p < 0.001); Peak expiratory flow rate (PEF): improved (8.50 ± 0.94 vs. 8.87 ± 0.92; p < 0.01); Peak inspiratory flow (PIF): improved (5.71 ± 1.16 vs. 6.58 ±1.08; p < 0.005)
128 Mughal et al. 2022reviewPeppermint oil, also enteric-coated capsules (Colpermin)Use in respiratory tract inflammation: unclear

Peppermint: Further Outcomes in Studies

Inhaled essential peppermint oil relieved pain more than the control, for example after joint replacement and disc surgery and during placement of a venous catheter in cardiac patients 254651. Before injections at the dentist, children with peppermint oil on the mucosa felt less pain than with lidocaine gel or ice 27. In dialysis patients, peppermint gel reduced puncture pain compared with usual care, similar to a cold pack 43. In menstrual pain, peppermint capsules relieved pain similarly to mefenamic acid, but additional painkillers were taken more often 30. Anxiety also decreased more under inhaled peppermint oil than in the control group, for example after operations and in acute coronary syndrome 2537515370. During placement of a venous catheter, no difference was shown for anxiety 46, and in children before dental treatment, peppermint scent acted more weakly than chamomile and lavender 42. The robustness is overall high, but it is based predominantly on small, sometimes non-blinded studies with short follow-up; results apply in each case to the tested form, such as inhalation, topical preparation or enteric-coated capsule, and are not interchangeable.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Wang et al. 2025meta-analysis · 2,062 participantsPeppermint extract (among 15 plant substances); vs. Standard treatmentQuality of life: unclear; Fatigue: unclear; Pain: unclear
2 Shetty et al. 2024meta-analysis · 1,495 participantsTopical peppermint, partly with lanolin and aloe vera; vs. Lanolin, aloe vera and/or controlNipple pain: improved; Nipple trauma: improved
5 Khanna et al. 2014systematic review · 726 participantsEnteric-coated peppermint oil capsules; at least 2 weeks; vs. PlaceboAdverse events
7 Fang et al. 2025meta-analysis · 690 participantsInhaled essential oils, including peppermint oil; vs. usual care and other essential oilsSleep quality: unclear
10 Mascarenhas et al. 2025meta-analysisAromatherapy with essential oils, including peppermint/mint; vs. Conventional treatment, other complementary therapies, or placeboMaternal anxiety: improved (SMD = -0.67; 95 % CI: -0.95, -0.40); Sleep quality: improved (mean difference = -1.55; 95 % CI: -2.09, -1.01)
11 Pezantes-Orellana et al. 2025systematic reviewEssential oils, including peppermint oil, in cosmetic formulationsEfficacy for skin conditions: unclear
16 Gonçalves et al. 2024systematic reviewPeppermint (Mentha piperita) as part of a mixtureAntipruritic effect: improved
18 Tahir et al. 2024meta-analysisAromatherapy, including peppermint oil (inhalation or massage); vs. Control/no aromatherapyPain score in primary dysmenorrhea: improved (SMD -3.19 (CI -5.09, -1.28; I² = 98%)); Pain score (RCTs): improved (− 0.98 (CI-1.40, -0.57; I² = 64%)); Moderate to severe pain: improved (RR: 0.39; CI 0.25, 0.60; I² = 36%)

Further studies in this area: 19 23 25 27 28 29 30 31 32 33 37 41 42 43 44 45 46 47 48 51 52 53 54 55 59 60 61 62 63 64 65 69 70 71 72 73 74 75 76 77 78 79 81 83 84 86 87 91 92 93 94 95 96 97 98 99 101 102 103 105 108 111 118 120 122 125 126 127 128 132 135

4. How Is Peppermint Dosed? Preparation, Dose and Duration in Studies

The studies mainly tested inhaled or ingested essential peppermint oil, enteric-coated capsules and peppermint extract. Peppermint tea was tested in one controlled trial on cognition. Some studies investigated mixtures with other essential oils or plant extracts, whose results cannot be attributed to peppermint alone. Externally, peppermint oil was tested as a gel on the skin and on the oral mucosa 2743.

Preparation or formDoseDurationStudy
Peppermint oil capsules (double-blind) and peppermint sweets (open-label)182 mg oil or 9.2 mg oil, 2-3 times daily, dose escalation allowed8 weeks intervention, 4 weeks follow-up22
Peppermint nutraceutical3 mL daily3 months intervention, 1 month washout23
Small-intestinal-release or ileocolonic-release peppermint oil182 mg per day8 weeks24
Inhalation of peppermint essential oil (aromatherapy)—3 days postoperatively (POD assessment)25
Double-blind peppermint oil, placebo, or treatment as usual—6 weeks26
topical peppermint gelthree times daily, thin layer on at-risk skin areasup to 14 days28
Lavender-peppermint essential oil pad—twenty minutes before biopsy29
Peppermint capsule (extract)—3 days from menstruation onset30
Peppermint cream—up to the fourteenth day31
peppermint oil aromatherapy massagebiweekly 15-min knee massagefour weeks, one-month follow-up32
Inhalation of peppermint essential oilthree drops of essential oil7 days33
Inhalation of 10% or 30% peppermint essential oil0.2 ml of 10% or 30% peppermint oilSingle application, measured after 10 minutes34
Peppermint essential oil nasal drops 1.5%Nasal drops, second dose after 15 min if neededFollow-up over 2 months35
pH-dependent peppermint oil capsules (Colpermin)—1 month36
Inhalation with 2% peppermint oil2% peppermint oil, inhalationbefore induction, preoperatively, immediately after extubation37

5. Is Peppermint Safe? Side Effects in Studies

The side effects were mostly mild and temporary, most commonly heartburn 5. Two meta-analyses found more adverse events with peppermint oil 36, another found no confirmed difference 4. In several controlled trials, peppermint oil was well tolerated, sometimes with no differences from placebo 450.

StudyReported side effects
3 Ingrosso et al. 2022Adverse events more frequent with peppermint oil (RR 1.57)
4 Alammar et al. 2019No difference: PO 9.3% vs. placebo 6.1%, RR 1.40 (95% CI 0.87–2.26), p = 0.16
5 Khanna et al. 2014More adverse events, mostly mild and transient; most common heartburn
6 Huang et al. 2022Peppermint oil group had significantly more adverse events than placebo
10 Mascarenhas et al. 2025Described as safe and effective, no specific data
11 Pezantes-Orellana et al. 2025Safety assessed, but no specific data on peppermint
17 Utz et al. 2024Safety and tolerability rated predominantly very good to acceptable
22 Vermeijden et al. 2026Adverse events mild and infrequent
24 Weerts et al. 2020Mild adverse events more common in both peppermint oil groups (P < .005)
25 Liu et al. 2025Adverse events as secondary endpoint, no numbers reported
26 Ballou et al. 2022Extraintestinal symptoms decreased in all groups; most had no new/worse symptoms
30 Masoumi et al. 2016Nausea and diarrhea lower than with mefenamic acid

6. What Remains Open: Limits of the Evidence

  • Many studies tested combination products with other active ingredients, so the finding cannot be attributed to peppermint alone.
  • Peppermint tea has so far been tested in a controlled way only for cognition; studies on digestion and nausea are still pending.
  • The participant numbers of many studies are small, and follow-up is usually short.
  • External application and ingestion were investigated separately and are not interchangeable.
  • Long-term studies are still pending, and in children with abdominal pain the results are contradictory 2236.

7. Bottom Line: What Is Established About Peppermint

Peppermint has been studied as tea, essential oil, enteric-coated capsules and extract. Nausea and irritable bowel are the best studied: after operations, inhaled peppermint oil relieved nausea more than the control 485773. For irritable bowel, peppermint oil capsules outperformed placebo for overall symptoms and abdominal pain in several meta-analyses 345. For endurance, two small studies contradict each other 6768; for migraine, peppermint oil nasal drops relieved headache more than placebo 35. For cognition and alertness, one randomized controlled trial with peppermint tea found better scores in healthy adults 64.

The side effects were mostly mild and temporary, most commonly heartburn 5; several meta-analyses found more adverse events with peppermint oil than with placebo 356. Overall, the data are broad, but many studies tested mixtures and small groups, and peppermint tea was not tested in a controlled way in most areas.

Frequently Asked Questions

How well has Peppermint been studied in humans?

We evaluated 146 human studies on Peppermint, including 55 randomised controlled trials and 17 meta-analyses or systematic reviews; the controlled studies include 4,562 participants in total. As of 24 October 2026.

Does Peppermint help with nausea? What the studies show

We evaluated one meta-analysis or systematic review, 14 controlled studies and 11 further studies; the controlled studies include 884 participants in total. Result of the controlled studies: mixed. Strength of evidence under our published rules: high. Sources: 191012

Does Peppermint help with irritable bowel syndrome? What the studies show

We evaluated 5 meta-analyses or systematic reviews, 5 controlled studies and 32 further studies; the controlled studies include 783 participants in total. Result of the controlled studies: mixed. Strength of evidence under our published rules: high. Sources: 3456

Does Peppermint help with cognition and alertness? What the studies show

We evaluated 3 controlled studies and 3 further studies; the controlled studies include 190 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: moderate. Sources: 13406478

Does Peppermint help with headache and Migraine? What the studies show

We evaluated 2 controlled studies and one further study; the controlled studies include 166 participants in total. Result of the controlled studies: mostly no difference. Strength of evidence under our published rules: low. Sources: 203562

Does Peppermint help with physical performance? What the studies show

We evaluated 2 controlled studies and one further study; the controlled studies include 21 participants in total. Result of the controlled studies: mostly no difference. Strength of evidence under our published rules: low. Sources: 676893

Does Peppermint help with functional dyspepsia? What the studies show

We evaluated one controlled study and 9 further studies; the controlled studies include 60 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: low. Sources: 5682104109

For which complaints is peppermint best studied?

Nausea and irritable bowel are the best supported. Inhaled essential peppermint oil relieved nausea after operations in several randomized controlled trials 37485773. For irritable bowel, peppermint oil was more effective than placebo in meta-analyses 3458.

Does peppermint tea work the same as capsules or oil?

The forms are not interchangeable. Peppermint tea was tested in one randomized controlled trial on cognition and showed better performance in healthy adults there 64. For nausea, irritable bowel and functional digestive complaints, there are no separate controlled tests of peppermint tea.

What should be considered with combination products?

Many studies tested peppermint in combination with other active ingredients, such as essential oils, caraway oil or herbal extracts. The results then apply to the mixture and cannot be attributed to peppermint alone.

Which side effects are known?

The side effects were mostly mild and temporary, most commonly heartburn 5. Two meta-analyses found more adverse events with peppermint oil 36, another found no confirmed difference 4. In several controlled trials, peppermint oil was well tolerated, sometimes with no differences from placebo 450.

Does peppermint help with physical performance or headaches?

There are only a few small studies on this with inconsistent results. In recreational runners, peppermint oil in water prolonged the time to exhaustion compared with placebo 67, in another small study endurance remained unchanged 68. For migraine, peppermint oil nasal drops relieved headache more than placebo and similarly to lidocaine 35.

Sources

  1. 1
  2. 2
  3. 3
    Ingrosso MR, Ianiro G, Nee J, Lembo AJ, Moayyedi P, Black CJ et al. · 2022
  4. 4
    Alammar N, Wang L, Wang L, Saberi B, Nanavati J, Holtmann G et al. · 2019
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
    Mascarenhas VHA, Caroci-Becker A, Nick JM, Sahin S, Drigo RTDC, Riesco ML et al. · 2025
  11. 11
    Pezantes-Orellana C, German Bermúdez F, Montalvo J, Packer T, Orellana-Manzano A · 2025
  12. 12
    Gergő D, Garmaa G, Tóth-Mészáros A, To UND, Fehérvári P, Harnos A et al. · 2025
  13. 13
  14. 14
  15. 15
  16. 16
    Gonçalves S, Fernandes L, Caramelo A, Martins M, Rodrigues T, Matos RS · 2024
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
    Complementary and alternative medicine for treatment of irritable bowel syndrome
    Shen YH, Nahas R · 2009
  22. 22
    Vermeijden NK, van der Feen C, Groeneweg M, Hummel T, Zagers D, Bertrams-Maartens I et al. · 2026
  23. 23
  24. 24
    Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ et al. · 2020
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
    Shanazi M, Farshbaf Khalili A, Kamalifard M, Asghari Jafarabadi M, Masoudin K, Esmaeli F · 2015
  32. 32
  33. 33
  34. 34
  35. 35
    Rafieian-Kopaei M, Hasanpour-Dehkordi A, Lorigooini Z, Deris F, Solati K, Mahdiyeh F · 2019
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
    Mousavi Vahed SH, Afiat M, Dadgar S · 2022
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
    Maghami M, Pour-Abbasi MS, Yadollahi S, Maghami M, Azizi-Fini I, Afazel MR · 2024
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
    Effect of Aromatherapy with Peppermint Oil on the Severity of Nausea and Vomiting in Pregnancy: A Single-blind, Randomized, Placebo-controlled trial
    Joulaeerad N, Ozgoli G, Hajimehdipoor H, Ghasemi E, Salehimoghaddam F · 2018
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
    Miranda Neto M, Meireles ACF, Alcântara MA, de Magalhães Cordeiro AMT, Silva AS · 2023
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
    Han JY, Moosvi Z, Duh E, Park S, Albers GC, Samarasena JB et al. · 2021
  76. 76
    Nemoto D, Utano K, Isohata N, Endo S, Kumamoto K, Koshimizu TA et al. · 2017
  77. 77
  78. 78
  79. 79
    Dilrukshi EAC, Ogino T, Ishikawa M, Kuroda H, Nomura S · 2024
  80. 80
  81. 81
    Warshaw EM, Peterson MY, DeKoven JG, Adler BL, Pratt MD, Belsito DV et al. · 2025
  82. 82
  83. 83
  84. 84
  85. 85
    Brennan JA, Brennan R, Bojka S, Green C, Lane T, Martins C et al. · 2025
  86. 86
  87. 87
    Czarnecki ML, Michlig JR, Norton AM, Stelter AJ, Hainsworth KR · 2022
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
    Abdelrahman SM, El Samak M, El-Baz LMF, Hanora AMS, Satyal P, Dosoky NS · 2024
  93. 93
  94. 94
  95. 95
  96. 96
    Massenet T, Bosman P, Schleich F, Guiot J, Gridelet G, Henket M et al. · 2026
  97. 97
  98. 98
    METHOD FOR TREATING PATIENTS WITH COMBINED PATHOLOGY OF GASTRODUODENAL AND BILE-EXCRETORY SYSTEMS
    PETRAKOVA VALENTINA STEPANOVNA, ZADOROZHNAJA NATAL JA ALEKSAND, UGOL NIKOVA OL GA IVANOVNA, BELOBORODOVA EHL VIRA IVANOVNA, BESPALOV ALEKSANDR NIKOLAEVICH, KARYMOVA KIRA NIKOLAEVNA et al. · 2006
  99. 99
  100. 100
  101. 101
  102. 102
  103. 103
  104. 104
    Pasta A, Formisano E, Calabrese F, Navazzotti G, Giannini EG, Savarino V et al. · 2026
  105. 105
    Iranitalab M, Ouanounou A · 2026
  106. 106
  107. 107
    Mohamed FA, Hassan MM, Aboulmagd YM, Attallah KA, Ghaiad HR, El-Shiekh RA et al. · 2026
  108. 108
  109. 109
    Moniruzzaman M, Shah A, Morrison M, Koloski N, Gwee KA, Chen M et al. · 2025
  110. 110
  111. 111
  112. 112
  113. 113
  114. 114
    Bor S, Özen H, Kalkan İH, Akyüz F, Çelebi A, Dinçer D et al. · 2025
  115. 115
    Marasco G, Cremon C, Salvi D, Meacci D, Dajti E, Colecchia L et al. · 2025
  116. 116
    Tursi A, Marinoni B, Privitera AC, Privitera L, Danese S · 2025
  117. 117
    Natural Products for the Treatment of Irritable Bowel Syndrome
    Brigstocke S, Brenner DM · 2025
  118. 118
    Gawish AS, ElMofty MS, Jambi S, Felemban D, Ragheb YS, Elsayed SA · 2024
  119. 119
  120. 120
    Serra J, Aguilar A, Barba E, Ciriza de Los Ríos C, Garcia Pravia L, Martínez V et al. · 2024
  121. 121
  122. 122
    Scarpellini E, Broeders B, Schol J, Santori P, Addarii M, Boccuto L et al. · 2023
  123. 123
  124. 124
  125. 125
    Kenda M, Kočevar Glavač N, Nagy M, Sollner Dolenc M · 2022
  126. 126
  127. 127
    Hatfield J, Saad S, Housewright C · 2022
  128. 128
  129. 129
  130. 130
  131. 131
  132. 132
  133. 133
    SYMPOSIUM REPORT: An Evidence-Based Approach to IBS and CIC: Applying New Advances to Daily Practice: A Review of an Adjunct Clinical Symposium of the American College of Gastroenterology Meeting October 16, 2016 • Las Vegas, Nevada
    Chey WD · 2017
  134. 134
  135. 135
  136. 136
  137. 137
    Stoicea N, Gan TJ, Joseph N, Uribe A, Pandya J, Dalal R et al. · 2015
  138. 138
  139. 139
  140. 140
    Vanuytsel T, Tack JF, Boeckxstaens GE · 2014
  141. 141
    Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths?
    Wu JC · 2010
  142. 142

Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.

International Health Research · https://ih-research.com/en/knowledge/peppermint/ · Last updated: 2026-10-24